The institute has the scientific knowledge, infrastructure and facilities to perform preclinical and clinical studies on request of pharmaceutical and biotechnological parties on a project-basis. The set-up of a prospective cohort to potential clients can be part of the service-offering. Our services include:
The combined in-depth knowledge of, among others, proteomics, pathology and clinical expertise can provided the industry new pathological pathways and related biomarkers.
The Neuroscience Campus Amsterdam has access to several in-house biobanks holding a variety of samples of the human brain, including the Twin register database, NESDO/NESDA, and the Netherlands Brain Bank.
Brain Imaging techniques are a vital component for characterisation of brain functions and brain morphology.
Through the combination of cellomics, genomics and proteomics, connections can be provided between the human genome and related phenotypes.
Various clinical departments and related clinics of VUmc and VU are affiliated with Neuroscience Campus Amsterdam.
Neuroscience Campus Amsterdam has access to large and extensive patient cohorts of VUmc and VU.
The infrastructure of Neuroscience Campus Amsterdam includes a Neuropathology section with unique expertise in the field of pathology.
During various research activities substantial amounts of data are generated.
A large number of in-house developed mutant mouse models, for example transgenic mouse models, are available at the institute in combination with the scientific expertise and related facilities.
We can offer high-throughput behavior assays in mice thereby strongly benefiting from the automated monitoring systems set up by the NeuroBasic PharmaPhenomics consortium using on-line video tracking 24/7.
Photonics is an advanced technology using optical imaging systems, including an in vitro imaging platform and an in vivo animal model.
Neuroscience Campus Amsterdam has recently set up a modern stem cell facility in combination with research expertise that can be used for investigations on stem cell development and therapies in for example mutant mouse models and, eventually, in man.
© Copyright VU University Amsterdam
